« Allos Therapeutics, Inc. Initiated Phase 2 Study of PDX (Pralatrexate) in Peripheral T-cell Lymphoma Patients | Main | Millenium Pharmaceuticals Initiates Phase I Trials for MLN0415 Drug Candidate Against Inflammatory Diseases »

Aug31
Compound Solutions Entered CoQ10 Agreement with Premier Chinese Manufacturer, HZH Pharmaceutical

Innovator of new products and distributor of nutritional ingredients, Compound Solutions, have agreed to represent Hangzhou Zhongmeihuadong Pharmaceutical (HZH) in the distribution of CoQ10 across North America and Europe.

CoQ10 is a powerful antioxidant and catalyst for ATP (energy production in the human body) that is essential for the optimal health and function of all cells, tissues and organs.

CoQ10, naturally occurring in the body, is found in small amounts in some foods, but at levels too low for therapeutic benefit, the amount of which depletes with age and in users of cholesterol-lowering statin drugs.

coq10-60.gifThe body will become chronically fatigued, and the immune system compromised when CoQ10 levels are below adequate. Its supplementation yielded positive clinical results in conditions including heart disease, chronic fatigue,Parkinson's disease and periodontal disease.

According to Compound Solutions CEO, Barry Titlow:

"We are honored HZH chose Compound Solutions to distribute its CoQ10 across North America and Europe. The synergy and experience of our two companies in CoQ10 research, production, marketing and new product development is unparalleled in the world. HZH and Compound Solutions presents a powerful resource for clients seeking a reliable, science-based source for one of the world's most widely used nutritional ingredients.”

Part of the larger Huadong Medicine Group, HZH is one of China's most prestigious pharmaceutical companies.

More details from the full press release.

related entries


0 Comments/Trackbacks




submit a trackback

TrackBack URL for this entry:

post a comment

Name, Email Address, and URL are not required fields.





Comment Preview

« Allos Therapeutics, Inc. Initiated Phase 2 Study of PDX (Pralatrexate) in Peripheral T-cell Lymphoma Patients | Main | Millenium Pharmaceuticals Initiates Phase I Trials for MLN0415 Drug Candidate Against Inflammatory Diseases »

Advertise

Watch the Digital Health Revolution


sponsored ads



subscribe


Prefer Email?
Subscribe below-

Enter your Email:


Powered by FeedBlitz What's this?

Current News

Support This Blog

top blogs

business social media

Use these fast growing business social media sites to promote your business, feature your products, spotlight your business leaders, create links, and drive traffic back to your company site, all for free!

BIZZlogos - Add your logo - free link to your site
BIZZphotos - Add photos of your products and people
BIZZprofiles - Submit your profile and build your online visibility
BIZZspotlight - Spotlight your business with free links
BIZZvideos - Videos about businesses, products and business people.
BIZZbites - "Digg" for Business - Submit your articles and posts

Know More Media - Health Care / Pharmaceutical / Fitness

know more media network

View Network Map

Network Feed List (OPML)

Know More Media Network
Feed


we support unitus

PRWeb

Influencer



PharmaGazette is a member of the Know More Media network of business related blogs.

Here are some current headlines from some of our business publications:

ProductivityGoal

CallCenterScript

AdHurl

TheBizofKnowledge

LandingTheDeal

CustomersAreAlways

HealthCareVox

BrainBasedBusiness

TheInsurancePolicy

MarketingBlurb